United States · 
Who invested in ZetaGen Therapeutics?
ZetaGen Therapeutics's investors include MedTech Innovator, National Cancer Institute (NCI) and New York Ventures.
20252026
$13MSeries B$13MRound
United States · Series B startup
Who invested in ZetaGen Therapeutics
Funding summaryUpdated 26 Oct 2026
$26Mraised across 2 rounds since 2025, from 2 sources
$13MSeries B$13MRound
- Latest round
- Round, $13MOct 2025
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $13M Jan 2025
- Biggest round
- $13M Round · Oct 2025
- Between rounds
- 10 months from the last two
The rounds
- Oct 2025Round$13M
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $13M sold, first sale Oct 2025
- Jan 2025Series B$13M3 new
Source recordedSEC filing: $83K sold, first sale Jan 2025
Founders and team
From ZetaGen Therapeutics's own website: 3 on the team.
- Joe C. LoyChief Executive Officer
- Compass RegulatoryManaging Director
- Compass Regulatory Inc.Partner Rubin and Rudman LLP
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
National Cancer Institute (NCI)Investment firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about ZetaGen Therapeutics
How much has ZetaGen Therapeutics raised?
ZetaGen Therapeutics has raised $26M across 2 rounds since 2025.
When did ZetaGen Therapeutics last raise?
ZetaGen Therapeutics's most recent round, $13M, was in Oct 2025.
What was ZetaGen Therapeutics's biggest round?
Its most recent round, $13M in Oct 2025, is also its largest on record.
Who backed ZetaGen Therapeutics first?
ZetaGen Therapeutics's first round on record, in Jan 2025, was backed by MedTech Innovator, National Cancer Institute (NCI) and New York Ventures.
What stage is ZetaGen Therapeutics at?
ZetaGen Therapeutics's latest named round is a Series B, in Jan 2025.
Where is ZetaGen Therapeutics based?
ZetaGen Therapeutics is based in the United States.
Companies like ZetaGen Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.